Company intelligence / Profile preview
Phoster Algamar
Redondela, Galicia, Spainalgamar.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Phoster Algamar is a Spanish biotechnology company focused on the research and development of bioactive compounds derived from marine macroalgae. The company leverages the biodiversity of the Atlantic coast to identify and extract high-value molecules with potential applications in the pharmaceutical, nutraceutical, and cosmetic industries. Their primary research focus involves exploring the anti-tumor and anti-inflammatory properties of seaweed-derived extracts. By combining traditional marine knowledge with modern biotechnological processes, Phoster Algamar aims to develop sustainable and natural therapeutic solutions.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculeNatural products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Algamar
Beyond the preview
Go deeper on Phoster Algamar.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phoster Algamar.